Wednesday, 19 June 2013
Ebos Group Ordinary Shares
NZX : EBO
9.400
19 Jun 13 16:59 | Change:
 0.11 | Open:
9.510 | High:
9.550 | Ask:
9.450 | Volume:
161,184 |
Change(%):
1.16 | Prev:
9.510 | Low:
9.400 | Bid:
9.400 | Avg vol:
0 |
EBOS Group Limited supplies a range of medical, surgical, retail, dental, and scientific products to the healthcare market in New Zealand and Australia. It operates in two segments, Healthcare and Scientific. The Healthcare segment engages in the sale of healthcare products, as well as in retail healthcare and wholesale activities. The Scientific segment provides laboratory consumables, life sciences equipment, and technical support to industry and research laboratories. Ebos Group Limited serves hospitals, primary care centers, rehabilitation/mobility centers, aged care facilities, and allergists, as well as scientific and consumer markets. The company was formerly known as Ebos Dental & Surgical Supplies LTD and changed its name to Ebos Group Limited in 1986. Ebos Group Limited is headquartered in Christchurch, New Zealand.
| Shares: | 65,546,270 |
|---|
| Issuer: | Ebos Group Limited |
|---|
| Solicitor: | Chapman Tripp Christchurch |
|---|
| Registry: | COMPUTERSHARE INVESTOR SERVICES LIMITED |
|---|
| Auditor: | Deloitte Christchurch |
|---|
| Settlement: | NZCDC Settlement System |
|---|
| Website: | http://www.ebos.co.nz/ |
|---|
| Market Cap: | $616,134,938 |
|---|
| 52 wk High: | 11.000 |
|---|
| 52 wk Low: | 7.450 |
|---|
| Sector: | Intermed & Durables |
|---|
| Div/Yield: | 9.790 |
|---|
| EPS: | 0.621 |
|---|
| Price/Earnings: | 11.980 |
|---|
| NTA: | 1.044 |
|---|
Ebos Group
108 Wrights Road
PO Box 411
Christchurch,
New Zealand
08:54 | 30/5/13
TrustLaw (blog)
--Drug wholesaler Symbion has been sold to New Zealand healthcare specialist EBOS Group for A$730.9 million, creating Australasia's largest wholesaler and distributor of healthcare products.
more»Hong Kong-based Zuellig Group will take a 40 percent stake in New Zealand pharmaceutical and veterinary goods company Ebos Group Ltd, which is buying its Australian pharmaceutical wholesaler Symbion, the companies said on Wednesday.
more»10:32 | 29/5/13
Businessweek
Ebos Group Ltd. will become the largest pharmaceutical wholesaler in Australia and New Zealand after agreeing a NZ$865 million ($700 million) takeover of Australia's Symbion Ltd.
more»09:49 | 29/5/13
New Zealand Herald
Ebos Group, the healthcare and animal care products company, has agreed to buy Zuellig Group's Australian pharmaceutical wholesaler and distributor, Symbion, in a $1.1 billion deal which will more than triple its annual revenues and make it a major ...
more»09:01 | 29/5/13
Stuff.co.nz
Christchurch-based Ebos Group has announced a $1.1 billion deal it says will transform it into a leading Australasian business with revenue in excess of $6b.
more»
-
17 June 2013
Dear Shareholder,
EBOS Share Entitlement - Action Required
At a Special Meeting held in Christchurch last Friday (14 June 2013),
Shareholders voted overwhelm
more»
-
EBOS SHAREHOLDERS OVERWHELMINGLY SUPPORT $1.1B SYMBION ACQUISITION
News Release Date: 14 June 2013
EBOS Group Limited (NZX: EBO) shareholders today voted overwhelmingly in
f
more»
-
10 June 2013
Listed Company Relations
NZX Limited
WELLINGTON
NOTIFICATION OF ALLOTMENT OF SECURITIES - BONUS ISSUE
For the purposes of Listing Rule 7.12.1, EBOS Group Limited
more»
-
7 June 2013
Listed Company Relations
NZX Limited
WELLINGTON
NOTIFICATION OF ALLOTMENT OF SECURITIES - PLACEMENT
For the purposes of Listing Rule 7.12.1, EBOS Group Limit
more»
-
Quotation Notice Renounceable Entitlements
(Rights) (EBORC)
Company Name: EBOS Group Limited
Prospectus Dated: 5 June 2013
Details of Offer: A pro-rata renounceable En
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|